ARCI backs enhanced NSAID and corticosteroid regs
Following a meeting on Monday, Aug. 5, the Drug Testing Standards and Practices (DTSP) Committee of the Association of Racing Commissions International (ARCI) endorsed instituting a 48-hour restriction on administration of nonsteroidal anti-inflammatory drugs (NSAIDS), which include Phenylbutazone, and a 14-day restriction on the administration of corticosteroids, pending scientific review.
The restriction on corticosteroids would not apply to harness racing, as the sport is currently amidst proceedings to determine breed-specific rules due to different race schedules for Thoroughbreds, Standardbreds and Quarter Horses.
The corticosteroids were previously included in the Model Rules but were removed per the instructions of the Racing Medication & Testing Consortium (RMTC). In a recent meeting of the RMTC, that organization recommended the 48-hour restriction on NSAIDs as the science is available to prove administration after that window can compromise a pre-race examination.
“There have been situations, specifically in New York, where these restrictions have been implemented and been quite successful,” said Ed Martin, ARCI president and past executive director of the New York Gaming and Wagering Board.
LATEST BUSINESS NEWS
Colonial Downs to have limited attendance
Colonial Downs will allow up to 1,000 fans in its grandstand and outdoor areas and will take other safety precautions in light of the coronavirus.
Off to the Races radio back for July 4 program
Off to the Races Radio returns July 4 with a great show featuring Delaware Park’s John Mooney and handicapper Barry Spears.
Parx Racing set to allow fans back
Fans and bettors will be permitted to attend the races at Parx Racing — with restrictions — starting Monday, July 6, the local horsemen’s group says.
Trainer Mark Casse joins WHOA
Trainer Mark Casse, a recent inductee to the Hall of Fame, has joined the Water Hay Oats Alliance in calling for passage of the Horseracing Integrity Act.
Fasig-Tipton: Solid sale despite uncertainty
While there was uncertainty entering the Fasig-Tipton 2-year-olds in training sale, the market turned out to be solid – especially for Maryland-breds.
Fasig-Tipton: 2yo sale surpasses $23 million
The two-day Fasig-Tipton Midlantic 2-year-old sale which concluded Tuesday surpassed $23 million in gross sales and included a seven-figure seller.
